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Radiographic ﬁndings of thick walled cavities in the lungs are typically seen in mycobacterial infections,
malignant lesions, fungal infections, pulmonary vasculitis or other inﬂammatory lesions of the lungs.
Necrotizing infections of the lungs caused by gram negative bacteria (Klebsiella, Psudomonas, Legionella)
and Staphylococcus aureusmay also form cavities of varying thickness, with consolidation. Escherichia coli
pneumonia causing pulmonary cavities is very rare and the few cases reported are of pneumatocele
formation. Here we present an unusual case of Escherichia coli infection as a rare cause of bilateral
cavitating necrotizing pneumoniae, in a 67 year old male with uncontrolled type 2 diabetes mellitus.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Case
A, 67 year old male, with no previously known comorbidities
presented to our hospital with fever, cough, generalized weakness
and low back ache since 1month. He gave a history of receiving oral
antibiotic treatment during the past month, but his symptoms did
not resolve. He was febrile, had tachycardia (108 beats/min), blood
pressure was normal (120/80 mm of Hg), and maintained oxygen
saturation of 96% in room air. A routine random blood sugar (RBS)
testing revealed very high blood glucose level (RBS- 704.2 mg/dl).
He was admitted for further investigation and management. His
blood sample was sent for analysis and he was started on a broad
spectrum antibiotic (intravenous ceftriaxone). His blood glucose
levels were controlled with insulin and oral anti-hyperglycemic
agents. He was also symptomatically treated with antipyretics,
bronchodilators and expectorants.
Upon investigation his chest radiograph showed bilateral mul-
tiple thick walled air ﬁlled cavities [Image 1]. High resolution
computed tomography (HRCT) of his lungs revealed multiple
evolving thick walled cavities in both lungs suggestive of Koch's
[Images 2, 3]. Based on the nature and duration of symptoms,
relentless course, diabetic status and classical radiographic ﬁndings
a clinical diagnosis of pulmonary tuberculosis was made. His
sputum samples were sent for acid fast bacilli (AFB) smear and heaguntepalya (Next to Yes-
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Ltd. This is an open access article uwas started on standard anti tubercular treatment (ATT) (Rifam-
picin 600 mg, INH 300 mg, Ethambutol 1 gm, and Pyrazinamide
1.5 gm, along with Pyridoxine). Two consecutive sputum samples
(early morning and evening of the same day) did not show any AFB
on smear. So the next day a further sample was sent for AFB smear,
bacterial culture and sensitivity, and PCR assay (GeneXpert-MTb/
Rif) for Mycobacterium tuberculosis.
His blood sugars were controlled with insulin, and oral anti-
hyperglycemic agents. He was also symptomatically treated with
antipyretics, bronchodilators and expectorants. His renal and liver
functions were evaluated and found to be normal.
Meanwhile the blood counts showed an elevated total count
(12,440) with relative neutrophilia (85.6%). His erythrocyte sedi-
mentation rate (ESR) was 62 mm/hr. The sputum culture grew
Escherichia coli (E. coli), resistant to most ﬁrst line antibiotics
including ceftriaxone. It was sensitive to gentamicin, amikacin,
meropenem and piperacillin/tazobactam. The GeneXpert-Rif report
was negative forMycobacterium tuberculosis. His blood culture was
sterile and no growth was noticed after 72 hours of incubation. He
continued to be febrile with fever spikes (between 100 and 102 deg
F).
In view of the conﬂicting evidences the scope of investigations
were broadened. A bronchoscopy was performed and bron-
choalveolar lavage (BAL) ﬂuid was obtained. The BAL ﬂuid sample
was analyzed for AFB smear and culture, gram's stain, bacterial
culture & sensitivity, fungal stain and fungal culture along with
study for presence of malignant cells. Ceftriaxone was stopped and
he was started on piperacillin/tazobactam. The BAL sample studiednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Image 1. Chest X-ray PA view showing bilateral cavities.
Image 2. HRCT-Thorax showing bilateral consolidation with a cavity in left upper lobe.
Image 3. HRCT-Thorax showing consolidation in right upper lobe and a cavity in the
apical segment right lower lobe.
Image 4. Repeat chest X-ray during follow up shows resolution of cavities.
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nant cells on smear. On bacterial culture the BAL sample grew E. coli
with a colony count of 104 cfu/ml, resistant to most ﬁrst line anti-
biotics including ceftriaxone, cefuroxime and ceﬁxime, with in-
vitro sensitivity to levoﬂoxacin, gentamycin, amikacin, mer-
openem and piperacillin/tazobactam. Over the next 1 week the
patient improved clinically. His cough decreased and he became
afebrile. A diagnosis of necrotizing pneumonia due to E. coli was
made and ATT was stopped. His blood sugars were well controlled
and dose of his oral anti-hyperglycemic drugs titrated and he was
discharged from the hospital.
He continued to receive parenteral piperacillin/tazobactam on
an out-patient basis for 10 days and he was followed up regularly.
His cough steadily decreased and serial chest radiographs on follow
up, over the next 4 months showed gradually resolving cavities.
During follow up, the BAL culture reports were received and theydid not grow any fungus and the culture was negative for AFB. The
cavities completely resolved at 4 months [Image 4].
2. Discussion
Cavitatory lesions in radiographs of the lungs can be seen in
infections, inﬂammation or malignancy of the lungs. However
certain conditions are more frequently associated with cavities
than others. Infection with Mycobacterium tuberculosis and fungi
tend to be chronic and are common causes of cavity formation in
the lungs [1]. Mycobacterim tuberculosis infection is classically
known to be associated with ﬁndings of cavities, both thick (wall
size >4mm) and thinwalled (wall size <4mm) in chest radiograph,
more frequently in patients with diabetes as a co-morbidity.
Finding of pulmonary cavitation, along with clinical history
N.S. Harsha et al. / Respiratory Medicine Case Reports 19 (2016) 125e127 127suggestive of pulmonary Koch's has signiﬁcant diagnostic value in
public health setting and prognostic value for the patient, especially
in endemic areas [1]. Indian guidelines for management of tuber-
culosis recommends that in individuals with clinical symptoms
suggestive of tuberculosis (cough for more than two weeks not
responding to antibiotic therapy) and showing radiographic ﬁnd-
ings of pulmonary tuberculosis, if the sputum is negative for AFB
should be classiﬁed as ‘sputum negative pulmonary tuberculosis’
and started on ATT [2].
Our patient came with clinical history of fever and cough for a
month inspite of receiving treatment. He had radiographic ﬁnding
of multiple thick walled cavities along with uncontrolled diabetes
status. His condition was strongly suggestive of pulmonary tuber-
culosis. Also a high resolution computerized tomography of his
lungs showed multiple evolving thick walled cavities suggestive of
pulmonary Koch's. He was started on ATT as per Indian Guidelines.
However two consecutive sputum smears were negative for AFB
which was very unlikely in cavitating tuberculosis.
So his sputum sample was sent for the gene-eXpert RIF test,
which again did not detect any Mycobacterium tuberculosis.
Therefore we looked at the possibility of other common causes for
thick walled cavities namely fungal infection and malignancy. Both
aspergilloma of the lung and primary malignancy of the lung are
also frequently known to present with cavitation in the lungs with
thickening of the cavity walls [1]. The sputum sample was sent for
fungal stains and it was found to be negative for fungal elements.
Meanwhile the sputum sample grew E. coli (moderate growth).
His blood counts also showed high total count with relative neu-
trophilia, indicating a possible bacterial infection rather than a
mycobacterial infection.
A bronchoalveolar lavage (BAL) was performed and the BAL ﬂuid
analyzed for presence of AFB, fungal elements, malignant cells and
bacterial culture. The BAL ﬂuid was also negative for AFB, fungal
elements andmalignant cells. Again the bacterial culture of the BAL
ﬂuid showed signiﬁcant growth of E. coli (104 cfu/ml), with a very
similar sensitivity pattern to the sputum culture, strongly sugges-
tive of E. coli being the causative organism.We also sent a sample of
the BAL ﬂuid for fungal culture and AFB culture in our attempts to
arrive at a deﬁnitive microbiological diagnosis.
In light of the overwhelming negative evidence against Myco-
bacterium tuberculosis as the possible infective agent, and the
positive evidence suggestive of Escherichia coli infection of the lung,
a diagnosis of necrotizing E. coli pneumonia was made and his ATT
was discontinued. It is not uncommon for acute bacterial infections
of the lung to cause necrotizing pneumoniae with cavitation. The
organisms generally implicated are Staphylococcus aureus and few
gram negative bacteria (Klebsiella, Psudomonas, Legionella) [1,3]. E.coli infections of the lungs are relatively rare [4], but there is a
reported rise in incidence of E. coli pneumonia in recent years, both
in hospital and community settings [5]. Our patient did not have E.
coli bacteremia and his blood culture was sterile. However it is
documented that E. coli pneumonia may occur due to ‘micro-
aspiration of upper airway secretions’ due to previous airway
colonisation by E. coli, especially in patients with underlying con-
ditions like diabetes mellitus [6]. Thick walled cavities in E. coli
pneumonia seem to be a rarity, although we came across few re-
ported cases of pneumatocele (thin walled air ﬁlled cavity) for-
mation due to E. coli infection [6]. A review of cavitary lesions of the
lung published by the American Society for microbiology does not
list E. coli as a causative organism [1].
In this backgroundwewish to report this case of E. coli infection
as a rare cause of cavitating pneumonia in an individual with un-
controlled diabetes mellitus. As E. coli infections become common
in community settings it becomes important to consider this or-
ganism as a potential cause for necrotizing pneumonia with cavity
formation, albeit rare.
In practice we frequently encounter cavitating lesions of the
lung with a clinical picture suggestive of mycobacterial etiology.
Although pulmonary Koch's would be the ﬁrst in the list of differ-
ential diagnosis, especially in endemic areas, in sputum negative
cases an attempt should be made to aggressively look for a possible
microbiological cause of the infection, other than Koch's.
Through this case we wish to emphasize the role of advanced
investigation techniques like ﬂexible bronchoscopy in arriving at a
deﬁnitive etiological diagnosis. By using all the diagnostic methods
available at our disposal it may be possible to pin the diagnosis in
many cases for effective treatment and to avoid over treatment. It
will also help us in identifying atypical presentations and add to the
evidence base.References
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